Author: admin

Care planning intervention for people with dementia who do not have regular contact with an informal carer

The HTA Programme is considering this topic for future commissioned research. The likely advert date for this topic, if prioritised, is November 2018. However, please note this is an indicative date, which may change or may not be advertised. The commissioning brief, published when the call opens, will provide details of the topic. If you would like notification of when HTA calls go live please sign up to receive our bulletin. If you have a comment or question about this potential future research topic, please email us at htafunding@nihr.ac.uk. Alternatively, if you are interested in contributing to the development...

Read More

18/80 Precision medicine (HTA Programme)

Application dates: 21 June 2018 to 06 November 2018 The Health Technology Assessment Programme is accepting stage 1 applications for this primary research topic: 18/80 Precision medicine. Applications that span the remit of more than one of the participating programmes (EME, HTA, and HSDR) are particularly welcomed. Please submit your application to the programme whose remit most closely matches the major part of your work. Find out more >...

Read More

Invention for Innovation (i4i) Product Development Awards – Call 17

Applications are invited for the NIHR Invention for Innovation (i4i) research proposals for translational R&D projects aimed at cultivating new techniques or technologies into innovative interventions which address existing or emerging healthcare needs. i4i supports projects developing innovative medical technology including medical devices, active implantable devices and in vitro diagnostic devices. i4i also supports projects which utilise and develop techniques or technologies from other industry sectors that could have a potential impact if applied in a healthcare setting. Find out more >...

Read More

Automated analysis of retinal imaging using machine learning techniques for computer vision

Working in close partnership with Moorfields, we have developed AI technology which we hope could improve the way eye diseases are diagnosed and treated and could ultimately help the millions of people across the globe affected by preventable or curable sight loss. PROBLEM(S) TO SOLVE Two million people in the UK live with sight loss that could have been prevented through earlier diagnosis and modern treatments. Currently, eyecare professionals use optical coherence tomography (OCT) scans to help diagnose eye conditions. These 3D images provide a detailed map of the back of the eye, but they are hard to read...

Read More

Viz.ai

Viz.ai leverages AI to detect early signs of time-sensitive medical conditions on imaging. Its first product, which received FDA clearance in February 2018, is a software platform that analyses brain CT scans using deep learning for large vessel occlusions (LVOs), or strokes, notifying a neurointerventional specialist within minutes. Its second FDA-approved product automates CT perfusion analysis, providing advanced brain imaging to help support treatment decisions. Context Typically, in the case of stroke, by the time it is diagnosed and an interventional team assembled, too much of a patient’s brain has been affected in order to be able to administer...

Read More